[PMID: 18478012] PubMed record related to this compound for laboratory literature review
Second, GLP-1 drugs have shown an incredible capacity for weight loss, but the complications and side effects, as well as the cost often make it prohibitive for long-term use
It is studied in research laboratories for its role in cellular signaling and peptide interaction pathways
University of Campania "Luigi Vanvitelli" #mdpihealthcare To view or add a comment, sign in New research published in the Foundations journal Crohns & Colitis 360 found that people with IBD who use GLP-1 medicationscommonly prescribed for diabetes and obesityhad a lower risk of major heart-related complications
People tolerate the medication differently, Garcia-Reyes said
Introduction Obesity, defined as a body mass index (BMI) 30, affects around 42% of adults in the United States ( 2 ) than men (11.5% vs